PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1109
https://www.valueinhealthjournal.com/article/S1098-3015(12)02822-7/fulltext
Title :
PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02822-7&doi=10.1016/j.jval.2012.08.1109
First page :
A392
Section Title :
Infection
Open access? :
No
Section Order :
610